🇪🇺 Liposomal Doxorubicin in European Union

Liposomal Doxorubicin (liposomal-doxorubicin) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Liposomal Doxorubicin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Liposomal Doxorubicin approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Liposomal Doxorubicin in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.